Cytokines and Cardiovascular disease: Exploring Inflammation & Clinical Outcomes
June 12, 2015EBAC Accredited symposium held on August 31 during ESC 2015, London, UK
Teaching slides posted below.
Inflammation in Acute Myocardial Infarction & Ventricular Remodelling
Dr. Matthias Nahrendorf,Boston, MA, USA
Inflammation and Thrombosis
Dr. Raffaele De Caterina,Chieti, Italy
Inflammation as target for therapy in atherothrombosis
Dr. Prof. Paul RidkerBoston, MA, USA
Educational objectives
- Review new insights into the influence of inflammatory leukocytes and cytokines on the repair of acute myocardial ischemic injury and on left ventricular remodeling and healing
- Review the current evidence implicating inflammation in promoting thrombosis and inhibiting endogenous thrombolysis
- Discuss the rationale for lowering vascular events by inhibition of inflammation
- Discuss the potential of current and future strategies targeting inflammation in cardiovascular disease such as methotrexate, colchicine, and inhibition of IL-1 beta and MAP kinases
- Outline current ongoing clinical development programs aimed at testing the inflammation hypothesis of cardiovascular disease
Educational programme & downloadable teaching slides
Co-Chairmen:
Peter Libby, MD - Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
Thomas F Lüscher MD - University Hospital Zurich, Zurich, Switzerland
Share this page with your colleagues and friends: